In this online, self-learning activity:
Endometrial cancer, a type of cancer that originates in the lining of the uterus, is the most common gynecologic cancer and the fourth most common cancer in women living in the United States. The vast majority of women are diagnosed with endometrial cancer after the age of 50, and the most common risk factors are obesity, diabetes, hypertension, and increasing age. Levels of the two hormone estrogen and progesterone fluctuate during the menstrual cycle, resulting in cell proliferation and differentiation that may lead to abnormalities that contribute to malignancies later in life. The costs associated with endometrial cancer may amount to tens of thousands of dollars per patient, depending on the stage of disease upon diagnosis.
The following HCPs: medical oncologists; physician assistants, nurse practitioners, and pharmacists who practice in oncology; and other clinicians who commonly encounter patients with recurrent or advanced endometrial cancer.
Commercial Support Disclosure: This program is supported by educational grants from Karyopharm.
This activity is free of charge.
Release Date: April 01, 2020 -- Expiration Date: April 01, 2022
Faculty: Daphne Stewart, MD
By the end of the session the participant will be able to:
ACCME Activity #0
ACCREDITATION FOR THIS COURSE HAS EXPIRED. YOU MAY VIEW THE PROGRAM, BUT CME / CE IS NO LONGER AVAILABLE AND NO CERTIFICATE WILL BE ISSUED.
As a provider of continuing medical education, it is the policy of ScientiaCME to ensure balance, independence, objectivity, and scientific rigor in all of its educational activities. In accordance with this policy, faculty and educational planners must disclose any significant relationships with commercial interests whose products or devices may be mentioned in faculty presentations, and any relationships with the commercial supporter of the activity. The intent of this disclosure is to provide the intended audience with information on which they can make their own judgments. Additionally, in the event a conflict of interest (COI) does exist, it is the policy of ScientiaCME to ensure that the COI is resolved in order to ensure the integrity of the CME activity. For this CME activity, any COI has been resolved thru content review ScientiaCME.
Faculty Disclosure: Daphne B. Stewart, MD, MS, Associate Clinical Professor, City of Hope National Medical Center, has no relevant financial discloses.
Disclosures of Educational Planners: Charles Turck, PharmD, has no relevant financial discloses.
Commercial Support Disclosure: This program is supported by educational grants from Karyopharm
*Required to view Printable PDF Version
Please take a few minutes to participate in the optional pre-test. It will help us measure the knowledge gained by participating in this activity.
Advances in Treating Triple-Negative Metastatic Breast Cancer: Optimizing Pharmacotherapeutic Management Strategies
Ovarian Cancer: Therapeutic Updates, Best Practices, and Emerging Treatments
Advanced prostate cancer: Optimizing management strategies